The quiet end of the consolidator trading as Meridian Freight Partners
A proper account of an operation that existed, and of what closing it cost.
The archive — 2024
Page 67 of 68 of this archive, newest first.
South Africa pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
A shortage listing ends. 20 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
A needle is a single-use instrument
A needle blunts on first use. Reuse is uncomfortable, and it is a documented contributor to lipohypertrophy.
Norway declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
From the floor in Hangzhou: 11 posters, one theme
Reported from the sessions, and from the two hours afterwards.
What the new Italy guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What a 23% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
The dose that got you here and the dose that keeps you here
The commonest real-world strategy in this drug class is the least studied one.
How to read the silence on a certificate you already hold
Our position is about documentation practice. It is not an allegation about anybody’s honesty, and we are explicit about the difference.
The quiet end of Calder Vale Peptides of Skipton
A proper account of an operation that existed, and of what closing it cost.
A shortage listing ends. 8 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Suzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
What the paperwork is for, and who it was designed to protect
The header identifies the batch, the table records the tests, and the footer says who is answerable. Two of the three are usually incomplete.
What STEP 4 and SURMOUNT-4 actually established
Two withdrawal-design trials tell us what happens when treatment stops. Neither tells us what the lowest effective maintenance dose is.
A supplier suspends shipping to Canada after 24 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Canada caps exenatide prescribing to 11 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What a 39% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
The glycated haemoglobin assay, and the eight conditions that break it
The assay is not the problem. The interpretation of a lagging integral as a current measurement is the problem.
Why PeptideMeter may run electrospray where another laboratory runs MALDI
A brief and unromantic tour of the interface between a liquid sample and a vacuum.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
From the floor in Xianning: 4 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Independent analysis puts a MKM cagrilintide lot at 98.9%, against 94.9% on the certificate
A reminder that a purity figure is the output of a method, and that methods differ.
Qingdao export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Stepping down against stopping: two decisions treated as one
These agents produce no dependence and no withdrawal syndrome. What a taper would be for is therefore a real question rather than an obvious one.
Forty-four per cent: reading the nausea figure properly
Trial adverse-event tables count episodes reported to a study nurse. They are the best data we have and they systematically under-record the mundane.
From vial to bench: what is recorded and what is assumed
Chain of custody, in a regulated setting, begins at sampling. Here it begins when the package arrives.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.